Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453374 | 0.87 | KDM4E (0.33) | KDM4EATML3MBTL1CYP19A1 | |
| SCHEMBL21453375 | 0.85 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL21453371 | 0.85 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL21453373 | 0.84 | KDM4E (0.36) | KDM4EATML3MBTL1CYP19A1 | |
| SCHEMBL21453954 | 0.82 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL22751678 | 0.76 | KDM4E (0.32) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL22751666 | 0.76 | KDM4E (0.32) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL22751682 | 0.76 | KDM4E (0.32) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL22751632 | 0.75 | CYP19A1 (0.33) | KDM4EATML3MBTL1CYP19A1 | |
| SCHEMBL22751636 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | KDM4E 3411/4885ATM 3884/4885L3MBTL1 2377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.